骨关节炎年在审查2025年:流行病学和治疗
Andrea Dell'Isola1, Filippo Recenti2, Benedetto Giardulli3
1Clinical Epidemiology Unit, Orthopaedics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Osteoarthritis and cartilage
|September 6, 2025
概括
骨关节炎的研究表明,全球的负担正在增加,肥胖和身体构成影响了严重程度. 针对肥胖症的新兴疗法,
科学领域:
- 关节病学
- 流行病学
- 药理学
背景情况:
- 骨关节炎 (OA) 是一个日益严重的全球健康问题,与肥胖和关节创伤相关的早期疾病的发病率越来越高.
- 身体构成 (高脂肪量,低脂肪量) 和并发症等因素显著影响骨关节炎的严重程度,进展和患者的结果.
- 目前治疗OA的策略,包括关节内注射和常规药物治疗,在治疗这种疾病方面效果有限.
研究的目的:
- 从2024年4月到2025年3月,审查骨关节炎 (OA) 研究的最新流行病学趋势和治疗进展.
- 确定关键的风险因素,并评估新兴的OA治疗的有效性.
- 综合这些发现,为未来的OA管理策略提供信息.
主要方法:
- 在2024年4月1日至2025年3月31日期间发表的英语研究进行了叙述性审查.
- 在MEDLINE数据库中查找了观察性纵向研究,系统审查,元分析和II-IV期随机对照试验 (RCT).
- 从1920篇选文章中,总共选出了41项研究,根据其与骨髓炎风险因素和治疗进展的相关性.
主要成果:
- 全球骨关节炎的负担正在增加, 早期发病病例的增加归因于肥胖和关节损伤.
- 身体构成的特点是高脂肪量和低脂肪量, 是关键的决定性因素.
- 新兴的治疗方法,如塞马格卢提德,在膝盖骨关节炎和肥胖患者中显著降低体重和疼痛,这表明通过减肥可能产生疾病修饰作用.
结论:
- 最近的研究强调了骨关节炎的复杂性和目前治疗选择的局限性.
- 专注于肥胖管理的疗法,以塞马格卢提德为例,为OA治疗提供了一个有前途的途径,需要进一步研究其疾病修饰潜力.
- 整合新陈代谢,生物力学和社会心理方面的个性化治疗策略对于促进骨关节炎治疗至关重要.
相关概念视频
01:31Osteoclasts in Bone Remodeling
3.1K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:21Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31
01:26Drug Administration and Therapy Phases: Overview
737
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
737
01:23Atherosclerosis IV: Nursing Management
50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50
01:20Asthma: Pathogenesis and Management
573
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
573